Biogen Inc.
BIIB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $21 | $18 | $20 | $22 |
| - Cash | $4 | $3 | $3 | $2 |
| + Debt | $7 | $7 | $7 | $7 |
| Enterprise Value | $23 | $22 | $24 | $27 |
| Revenue | $2 | $3 | $2 | $2 |
| % Growth | -7.2% | 8.8% | -1% | – |
| Gross Profit | $2 | $2 | $2 | $2 |
| % Margin | 64.3% | 64.2% | 76.2% | 76.2% |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 33.7% | 42% | 35.6% | 28.2% |
| Net Income | $0 | $1 | $0 | $0 |
| % Margin | 19% | 24% | 9.9% | 10.9% |
| EPS Diluted | 3.17 | 4.35 | 1.64 | 1.83 |
| % Growth | -27.1% | 165.2% | -10.4% | – |
| Operating Cash Flow | $1 | $0 | $0 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $1 | $0 | $0 | $1 |